Table of Contents
Chapter 1. Global Radiopharmaceuticals Market Executive Summary
1.1. Global Radiopharmaceuticals Market Size & Forecast (2022- 2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Type
1.3.2. By Application
1.3.3. By Radioisotope
1.3.4. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Radiopharmaceuticals Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Radiopharmaceuticals Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Prevalence of Chronic Diseases
3.1.2. Technological Advancements in Imaging Modalities
3.1.3. Investments in Healthcare Infrastructure
3.2. Market Challenges
3.2.1. High Development and Production Costs
3.2.2. Stringent Regulatory Requirements
3.3. Market Opportunities
3.3.1. Novel Radiopharmaceuticals for Precision Medicine
3.3.2. Public-Private Partnerships for R&D
3.3.3. Digital Health Technologies for Personalized Travel Health Advisories
Chapter 4. Global Radiopharmaceuticals Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Radiopharmaceuticals Market Size & Forecasts by Type 2022-2032
5.1. Segment Dashboard
5.2. Global Radiopharmaceuticals Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Diagnostic
5.2.2. Therapeutic
Chapter 6. Global Radiopharmaceuticals Market Size & Forecasts by Application 2022-2032
6.1. Segment Dashboard
6.2. Global Radiopharmaceuticals Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Cancer
6.2.2. Cardiology
6.2.3. Others
Chapter 7. Global Radiopharmaceuticals Market Size & Forecasts by Radioisotope 2022-2032
7.1. Segment Dashboard
7.2. Global Radiopharmaceuticals Market: Radioisotope Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Technetium 99m
7.2.2. Gallium 68
7.2.3. Iodine I
7.2.4. Fluorine 18
7.2.5. Copper 64
7.2.6. Strontium 89
7.2.7. Yttrium 90
7.2.8. Radium 223
7.2.9. Actinium 225
7.2.10. Lutetium 177
7.2.11. Copper 67
7.2.12. Terbium 161
7.2.13. Zirconium 89
7.2.14. Others
Chapter 8. Global Radiopharmaceuticals Market Size & Forecasts by End User 2022-2032
8.1. Segment Dashboard
8.2. Global Radiopharmaceuticals Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Hospitals and Clinics
8.2.2. Medical Imaging Centers
8.2.3. Others
Chapter 9. Global Radiopharmaceuticals Market Size & Forecasts by Region 2022-2032
9.1. North America Radiopharmaceuticals Market
9.1.1. U.S. Radiopharmaceuticals Market
9.1.1.1. Type breakdown size & forecasts, 2022-2032
9.1.1.2. Application breakdown size & forecasts, 2022-2032
9.1.1.3. Radioisotope breakdown size & forecasts, 2022-2032
9.1.1.4. End User breakdown size & forecasts, 2022-2032
9.1.2. Canada Radiopharmaceuticals Market
9.2. Europe Radiopharmaceuticals Market
9.2.1. U.K. Radiopharmaceuticals Market
9.2.1.1. Type breakdown size & forecasts, 2022-2032
9.2.1.2. Application breakdown size & forecasts, 2022-2032
9.2.1.3. Radioisotope breakdown size & forecasts, 2022-2032
9.2.1.4. End User breakdown size & forecasts, 2022-2032
9.2.2. Germany Radiopharmaceuticals Market
9.2.3. France Radiopharmaceuticals Market
9.2.4. Spain Radiopharmaceuticals Market
9.2.5. Italy Radiopharmaceuticals Market
9.2.6. Rest of Europe Radiopharmaceuticals Market
9.3. Asia-Pacific Radiopharmaceuticals Market
9.3.1. China Radiopharmaceuticals Market
9.3.2. India Radiopharmaceuticals Market
9.3.3. Japan Radiopharmaceuticals Market
9.3.4. Australia Radiopharmaceuticals Market
9.3.5. South Korea Radiopharmaceuticals Market
9.3.6. Rest of Asia Pacific Radiopharmaceuticals Market
9.4. Latin America Radiopharmaceuticals Market
9.4.1. Brazil Radiopharmaceuticals Market
9.4.2. Mexico Radiopharmaceuticals Market
9.4.3. Rest of Latin America Radiopharmaceuticals Market
9.5. Middle East & Africa Radiopharmaceuticals Market
9.5.1. Saudi Arabia Radiopharmaceuticals Market
9.5.2. South Africa Radiopharmaceuticals Market
9.5.3. Rest of Middle East & Africa Radiopharmaceuticals Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Novartis AG
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Telix Pharmaceuticals Limited
10.3.3. Curium Pharmaceuticals
10.3.4. Lantheus Holdings, Inc.
10.3.5. GE Healthcare
10.3.6. Cardinal Health, Inc.
10.3.7. Bayer AG
10.3.8. Bracco Imaging S.p.A.
10.3.9. Jubilant Pharma Limited
10.3.10. Advanced Accelerator Applications S.A.
10.3.11. Actinium Pharmaceuticals, Inc.
10.3.12. Eckert & Ziegler Group
10.3.13. NorthStar Medical Radioisotopes, LLC
10.3.14. Nordion (Canada) Inc.
10.3.15. PharmaLogic Holdings Corp.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes